Diseases & conditions

Trump Admin Moves Medical Marijuana to Schedule III

Is rescheduling marijuana a long-overdue reform that expands access or a dangerous move that worsens a growing addiction crisis?

Published APR 23

Trump Admin Moves Medical Marijuana to Schedule III

Story

Image credit: Unsplash

The Spin

Pro-establishment narrative

Rescheduling marijuana is a long-overdue common-sense reform that expands patient access and removes unnecessary research barriers. Keeping cannabis alongside heroin while prescription painkillers caused a nationwide opioid crisis was never logical. This move empowers doctors to make better-informed health care decisions and delivers on a real promise to modernize federal drug policy.

Eric Daugherty on X

Todd Blanche on X

Austin Wade Petersen on X

Establishment-critical narrative

Rescheduling marijuana sends the wrong message at the worst possible time — addiction rates are surging, with roughly 18 million Americans using cannabis 21 or more days a month. High-potency modern products are driving emergency room visits, psychotic episodes and impaired driving fatalities at alarming rates. Loosening marijuana policy will produce worse outcomes than expected.

Heartland Journal on Substack

Joab Martínez on X

Cynical narrative

The Justice Department's move to reclassify some medical marijuana as a less dangerous Schedule III drug signals a major policy shift, but it does not legalize cannabis nationwide. The change mainly affects state-licensed medical use, easing research and regulation, while federal law still prohibits broader recreational use, leaving a complex patchwork between state and federal rules.

The Hill

Grinspoon: Grinspoon on Drugs on X